Catalyst Capital Advisors’s Sanofi Contingent Value Rights GCVRZ Stock Holding History
Bought
Maintained
Sold
Other funds holding GCVRZ
MCM
CPM
GCM
CL
Catalyst Capital Advisors's GCVRZ Position: Q2 2015 in Review
Catalyst Capital Advisors sold out of Sanofi Contingent Value Rights (GCVRZ) in Q2 2015, closing a stake of 300,000 shares — an estimated $203K sold.
Catalyst Capital Advisors first reported a position in GCVRZ in Q2 2013 and held it in 8 quarters. The position peaked at $237K in Q4 2014. 116 funds tracked by Wall St. Rank hold GCVRZ as of Q2 2015.
- Catalyst Capital Advisors reported no remaining Sanofi Contingent Value Rights position as of Q2 2015 after selling out during the quarter.
- Catalyst Capital Advisors sold 300,000 Sanofi Contingent Value Rights shares in Q2 2015, an estimated $203K.
- Catalyst Capital Advisors first reported a position in Sanofi Contingent Value Rights in Q2 2013 and held it in 8 quarters.
- Catalyst Capital Advisors's Sanofi Contingent Value Rights position peaked at $237K in Q4 2014.
- 116 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q2 2015.
Based on Catalyst Capital Advisors's 13F filing for Q2 2015, filed 12 Aug 2015.